
Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies
NETCast
00:00
DLL3 ADCs and Radioligand Approaches
Aman Chauhan discusses ADCs and DLL3-targeted radioligands as complementary strategies after T-cell engagers.
Play episode from 24:57
Transcript


